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ABSTRACT 
Objective: A simple, selective, precise and stability-indicating RP-HPLC-method was developed and validated for the determination of xipamide (XIP).  
Methods: Stability tests were done through exposure of the analyte solution to thermal, photolytic, hydrolytic and oxidative stress conditions. The 
chromatographic separation was carried out in less than five min on a RP stainless-steel C-18 analytical column (150 mm ×4.6 mm ID, 5 µm) with an 
isocratic elution system of 0.023 M orthophosphoric acid of pH 2.6 and acetonitrile as the mobile phase in the ratio of 60: 40 at 1.5 ml/min flow rate 
at room temperature. A diode array UV was used at 220 nm for detection.  
Results: The degradation products were well separated from the pure drug. The elution time of XIP was found to be 4.561±0.024 min. The method 
was validated in terms of linearity, accuracy, precision, limit of detection (LOD), limit of quantitation (LOQ) and robustness. Good linearity was 
found in the concentration range of 1–100 µg/ml with a correlation coefficient of 0.9999. Intraday and interday precision were within 1.4%. LOD 
and LOQ were 0.088 μg/ml and 0.267 μg/ml, respectively and percentage recovery of XIP was found to be 99.92±1.02 %.  
Conclusion: The proposed method was successfully applied to the determination of XIP in pure form and in its pharmaceutical preparation without 
interference from its degradation products. 
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INTRODUCTION 
XIP is 4-chloro-2, 6-dimethyl-5-sulfamoylsalicylanilide [1]. It has a 
moderately powerful diuretic action and is used for the treatment of 
high blood pressure and edema [2]. It decreases active reabsorption 
of sodium and accompanying chloride by binding to the chloride site 
of the electroneutral Na+/Cl-co-transport system and inhibiting its 
action [3]. The structural formula of XIP is shown in fig. 1.  
 
 
Fig. 1: Chemical structure of XIP 
 
Despite its wide use, few procedures have been developed for its 
determination. These include spectrophotometry [4-6], spectro-
fluorimetry [6], TLC-densitometry [5] and HPLC [7-12]. However, 
there is no reported LC method for stability determination of XIP, so 
the development of a simple, reproducible and selective analytical 
HPLC method would greatly aid in XIP stability determination either 
in pure or dosage forms.  
The present manuscript describes the degradation behavior of XIP 
under acidic, basic, oxidative and photolytic conditions. Optimization 
of LC conditions to separate the drug from its degradation products 
on a RP C18 column in less than 5 min and method validation were 
also achieved. 
MATERIALS AND METHODS 
Chemicals and reagents  
Pharmaceutical grade XIP (99.09%) was kindly provided by EIPICO 
Pharmaceutical Industries Company, Cairo, Egypt. Analytical reagent 
grade chemicals were used in all experiments. HPLC grade methanol, 
acetonitrile (TEDEA, Fairfield, USA). HCl, NaOH and H2O2 (Merck, 
USA), orthophosphoric acid 85% (Burdick & Jackson, USA) were 
used. Fresh double distilled water was used throughout the analysis. 
The pharmaceutical preparation used was Epitens® (EIPICO, Egypt, 
10 mg and 30 mg triamterene/tablet). 
Instrumentation and chromatographic conditions 
HPLC apparatus (Agilent 1100) consisted of quaternary pump 
G1310A with solvent cabinet quaternary, vacuum degasser G1322A 
and a four-channel gradient pump; autosampler G1313A, variable 
wavelength detector (VWD) G1314A with the standard flow cell 10 
mm path length, 14 μl volume, 40 bar maximum pressure. LC 
separations were performed on an Agilent 5 µm Hypersil BDS C18 
column (150 mm x 4.6 mm ID). pH meter (Metrohm, USA) was used. 
For the determination of XIP and its degradation products, an 
isocratic mobile phase consisting of 0.023 M orthophosphoric acid of 
pH 2.6 and acetonitrile as the mobile phase in the ratio of 60: 40 was 
used, 1.5 ml/min flow rate at room temperature. pH is adjusted 
using H3PO4 and NaOH. 10 µl of sample was injected each run. 
Detection was achieved at 220 nm. 
Preparation of stock solutions  
Standard stock solution of XIP (0.1 mg/ml) was prepared by dissolving 
10 mg of the drug in methanol, sonicated and completed to 100 ml 
with methanol in a 100 ml volumetric flask. The standard working 
solutions were prepared by diluting aliquots of the stock solution with 
methanol to obtain concentrations ranging from 1–140 µg/ml. 
Construction of calibration curves 
The calibration graph was constructed by plotting the peak areas 
obtained at wavelength 220 nm against the corresponding injected 
concentrations of XIP. 
Assay of tablets 
A total of 10 tablets of Epitens® were finely powdered. An accurately 
weighed quantity of the powder equivalent to 10 mg XIP was 
International Journal of Pharmacy and Pharmaceutical Sciences 
ISSN- 0975-1491                 Vol 8, Issue 5, 2016 
Sayed et al. 
Int J Pharm Pharm Sci, Vol 8, Issue 5, 366-371 
367 
transferred into 100-ml volumetric flask and extracted using 25 ml 
methanol and then completed to 100 ml with methanol. The flask 
was shaken for 15 min using an ultrasonic shaker. The solution was 
then filtered into a dry conical flask. It was serially diluted and then 
injected. The concentrations of XIP were calculated using calibration 
equation. 
Forced degradation studies of xipamide 
The stock solution was used for the forced degradation study to 
provide an indication of the stability indicating property and 
specificity of proposed method. 
Acid and base-induced degradation 
A 1 ml of methanolic stock solution was transferred into 10 ml 
volumetric flask and the volume was completed with 2 N HCl. 
Alkaline degradation study was carried out in a similar manner 
using 0.1 N NaOH. These experiments were left at 80 °C for 2 h.  
Hydrogen peroxide-induced degradation 
To a 1 ml of methanolic stock solution, 2 ml of 30 % H2O2 was added, 
and the mixture was diluted with water to 10 ml. It was left at 80 °C 
for 2 h.  
Sunlight degradation 
The photochemical stability of the drug was also studied by exposing 
the standard methanolic solution of XIP to sunlight for 4 h. 
10 µl of all the above resultant stressed solutions were injected onto 
the column, and the chromatograms were run as described. 
RESULTS AND DISCUSSION 
Optimization of HPLC conditions 
In order to maximize the resolution and sensitivity of the proposed 
HPLC method for the separation of XIP and its degradation products, 
different experimental conditions were studied and optimized. This 
was performed at a detection wavelength of 220 nm which provided 
the best resolution.  
Type of organic modifier 
Isocratic elution using different proportions of acetonitrile in the 
mobile phase was tried.  
Detection was carried out at 220 nm to obtain good peak intensity 
for both drug and degradation products. Optimum resolution with 
good separation of the drug and its degradation products was 
achieved within reasonable run time (Less than 5 min) using 
isocratic elution system of 0.023 M orthophosphoric acid of pH 2.6 
and acetonitrile as the mobile phase in the ratio of 60:40. The 
retention time of XIP was found to be 4.561±0.024 min (fig. 2). At 
lower concentration of acetonitrile (35%), XIP peak with its 
degradation products co-eluted together resulting in tailing and 
distortion of the peak shape as in the case of alkaline degradation 
(fig. 3) (A). 
pH of the aqueous phase 
Various pH values ranging between 2.4 and 5.0 (adjusted using 
H3PO4 and NaOH) were used to study the influence of pH of the 
aqueous phase on the separation of XIP and its degradation 
products. It was observed that as the pH value increases, retention 
time (tR) of XIP decreases (tR was 3.587 min at pH 4 and 2.534 min at 
pH 5). In addition, XIP and its degradation products co-eluted as in 
case of alkaline degradation at pH 5 (fig. 3) (B). Thus, pH 2.6 was 
chosen as working pH providing maximum peak resolution and 
symmetry. 
Effect of flow rate 
It was noticed that the increase in flow rate does not have a 
significant effect on the separation, but it clearly shortens the 
analysis time. Decreasing flow rate to 1.0 ml/min increases the 
retention time for XIP and its degradation products as for sunlight 
degradation (fig. 3) (C). 
 
 
Fig. 2:A typical chromatogram of a 10 μl injection of a standard 
solution of XIP (90 μg/ml) using 0.023 M orthophosphoric acid 
(pH 2.6) and acetonitrile as the mobile phase (60: 40) at a flow 




Fig. 3: A typical chromatogram of a 10 μl injection of a standard mixture of XIP (100 μg/ml) using (A) 35% acetonitrile (B) Alkaline 
degradation at pH 5.0 (C) Sunlight degradation using 35% ACN, flow rate = 1.0 ml/min and the other chromatographic conditions as 
optimized 
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Degradation behavior 
Acid and base-induced degradation 
A previous study [13] confirmed that XIP was stable in acidic as well 
as in basic media at room temperature, so at a lower temperature no 
degradation was observed. When XIP was treated with strong acid 
(2 N HCl) at 80 °C for 2 h, a significant degradation of XIP was 
obtained with the appearance of an additional peak at 0.690 min (fig. 
4) (A). The effect of heat in acidic degradation is weaker than that in 
alkaline degradation. For alkaline degradation, when XIP was 
treated with 0.1 N NaOH at 80 °C for 2 h, the nearly complete 
disappearance of the intact drug occurred with the appearance of 
additional peaks (fig. 4) (B) and (C). 
Hydrogen peroxide-induced degradation 
Weak degradation of XIP was observed under oxidative conditions. 
It was found that treating XIP with 30 % H2O2 for 2 h at 80 °C 
resulted in the appearance of an additional peak at 1.760 min (fig. 4) 
(D). The oxidative degradation pathway of XIP was expected to be 
through the oxidation of the phenolic hydroxyl group with the 
formation of the quinonoid structure as in the case of ethamsylate 
drug previously reported [14]. 
Photolytic degradation 
A methanolic solution of XIP was somewhat stable to sunlight. After 
exposure to sunlight for about 4h, a small peak appeared at 0.819 min, 
so it must be stored in brown and air tight containers (fig. 4) (E).  
Although there were several degradation products, there was no 
interference with the peak of the intact drug, indicating that the 
method is stability-indicating. In addition, no reported LC method 
was developed for the determination of XIP stability until now. 
Method validation 
The developed analytical method was validated by means of 
linearity, accuracy, precision, LOD, LOQ and robustness according to 
the International Conference on Harmonization (ICH) guidelines 
(ICH 2005) [15]. 
 
 
Fig. 4: HPLC chromatogram of XIP degradation using (A) 2 N HCl (B) 0.1 N NaOH (C) 0.1 N NaOH spiked with 100 μg/ml XIP standard 
solution (D) 30% H2O2 for 2 h at 80 °C. (E) Sunlight exposure for 4 h 
 
Linearity 
Under the optimal experimental chromatographic conditions a good 
linearity of the calibration curve was obtained between the peak 
areas of XIP and the concentration range which was verified by the 
high correlation coefficient as mentioned in table 1. 
LOD and LOQ 
LOD was determined by evaluating the lowest concentration of XIP 
that can be readily detected. 
LOQ was determined by establishing the lowest concentrations that 
can be quantified. 
The values of LOQ and LOD were calculated according to the 
following equations:  
LOD = 3.3 SD/b 
LOQ = 10 SD/b 
Where SD is the standard deviation of the intercept of the regression 
line and b is the slope of the calibration graph. 
Specificity and accuracy 
Specificity is the ability of the analytical method to measure the 
analyte response in the presence of interferences. The comparison 
between the chromatogram of the raw XIP and that of extracted XIP 
from Epitens® tablets indicates that the excipients in the 
formulation did not interfere with the determination of XIP which 
indicates the specificity of the method (fig. 5). 
 
Table 1: Regression and statistical parameters for the 
determination of XIP using the proposed HPLC method 
System suitability  
tR±SD (min) 4.543±2.39×10-2 
N 10402 
k´ 3.549 
Linearity and Regression Data  
Linearity range (µg/ml) 1-100 
LOD (µg/ml) 0.088 
LOQ (µg/ml) 0.267 
Slope (b)* 5.6523 
Intercept (a)* -0.8476 
Correlation coefficient (r2)*  0.9999 
* Regression equation for the peak area of XIP against the 
concentration of XIP. 
 
The accuracy of the proposed method was expressed in terms of % 
recovery of 5 different concentrations (injected in triplicates). Results 
show high accuracy with good recoveries of 99.92±1.02 (table 2). 
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Fig. 5: Application of the proposed HPLC method for the 
determination of XIP in Epitens® tablets under the optimized 
chromatographic conditions 
 In addition, the results obtained using the proposed HPLC method 
were statistically compared with those obtained with the reported 
HPLC method [7]. The results in table 3 indicate that the calculated t 
and F values are less than the corresponding tabulated ones [16]. 
This proves that there is no significant difference between the 
suggested method and reference one, regarding accuracy and 
precision. 
Precision 
Results in table 4 show that there were high intraday and interday 
precisions (both within 1.4%). Intra-day precision was assessed by 
injection of the standard solution at three concentrations three 
times during a day. The same was done for interday precision test 
except that the injection of the samples was every day for three days. 
 
Table 2: Application of the proposed HPLC method for determination of XIP in Epitens® tablets 
Taken concentration (µg/ml) Found concentration (µg/ml) Recovery (%)* 
40.00 40.07 100.17 
50.00 50.15 100.29 
60.00 59.89 99.82 
90.00 90.94 101.04 
100.00 98.29 98.29 
Mean  99.92 
SD  1.02 
RSD  1.016 
* Average of three experiments 
 
Table 3: Determination of XIP by the proposed HPLC method compared with reported method 
Parameter HPLC method Reported method 
Mean ± SD 99.53 ± 0.90 98.31 ± 1.39 
RSD (%) 0.908 1.42 
Student-t-test 1.77 (1.78)* -- 
F-test 2.38 (3.84)* -- 
n 9 5 
*p<0.05. 
 
Table 4: Intraday and interday precision for the simultaneous determination of XIP using the proposed HPLC method 
Added concentration (µg/ml) Mean* % recovery±SD RSD (%) Mean* % recovery±SD RSD (%) 
30 101.19±0.54 0.537 99.82±0.75 0.753 
60 101.39±1.40 1.382 99.78±0.24 0.237 
90 101.58±0.94 0.922 100.65±0.32 0.322 
* Average of three experiments 
 
Fig. 6: Robustness of the proposed HPLC method indicated from a typical chromatogram of a 10 μl injection of a standard mixture of 90 
μg/ml XIP using (A) pH 2.4 (B) acetonitrile 39% (C) pH 2.8 and the other conditions as optimized 
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Fig. 7: Robustness of the proposed HPLC method indicated from a typical chromatogram of a 10 μl injection of a standard mixture of 90 




The robustness of an analytical procedure is a measure of its 
capacity to remain unaffected by changes in pH, flow rate, % of 
acetonitrile and wavelength of detection. pH was changed from 2.6 
to 2.4 and 2.8. The flow rate of the mobile phase was changed from 
1.5 ml/min to 1.4 and 1.6 ml/min. The organic strength was varied 
by±1% and wavelength of detection was changed by ±1 nm. The 
slight variations in the examined factors had no significant effect on 
the shape of the peak. 
The slight decrease in pH and % of acetonitrile led to increasing in 
retention time (fig. 6) (A) and (B). In addition, the slight increase in 
pH and % of acetonitrile led to decrease in retention time with no 
effect on peak area in both cases (fig. 6) (C) and (D). The small 
change in flow rate and wavelength of detection had no significant 
effect on retention time and peak area (fig. 7) (A) and (B) except the 
peak area that increased in case of increasing flow rate and 
decreasing wavelength of detection, (fig. 7) (C) and (D). 
CONCLUSION 
A simple, precise, selective and stability indicating RP-HPLC method 
was developed and validated for the determination of XIP and its 
degradation products. The degradation behavior of XIP was studied 
under acid, alkali, oxidation and photolysis conditions. Short 
chromatographic run time in less than 5 min allowing the analysis of 
a large number of samples in a short period of time so the proposed 
LC method can be used for the quality control of the cited drug. 
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